Clene Showcases CNM-Au8(R) at Investor Conferences
Clene (NASDAQ: CLNN) presents CNM-Au8(R) at investor conferences, showcasing its potential for treating neurodegenerative diseases. Learn more about Clene's participation and the development of CNM-Au8(R).
This news matters as it highlights the participation of Clene in important investor conferences, providing insight into the development of CNM-Au8(R) and its potential impact on treating neurodegenerative diseases.